Experts say 85% price drop in empagliflozin expected to boost SGLT2 usage; SGLT-2 class of drugs account for 25-30% of all ...

Researchers sourced data from the EASE-2 and -3 clinical trials to assess the effect of SGLT2i use on cardiovascular disease risk among patients with type 1 diabetes.

Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Empagliflozin significantly reduces acute kidney injury and renal failure risks in HF patients, reinforcing its renoprotective effects. Bridging the gap between research and practice is essential ...

VTV.vn - Boehringer Ingelheim recently partnered with the Vietnam Heart Association to host the scientific symposium "A ...

Almost 38 out of the total formulations for which the prices fixed in the meeting were of various formulations and strengths comprising empagliflozin, the anti-diabetes drug for which Boehringer ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

The country’s pharmaceuticals market grew by 8.4 per cent during financial year 2024-25 on the back of major therapies showing positive value growth, according to market research firm Pharmarack.

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from ...

Goldman Sachs expects Suven Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to grow at a Compounded Annual Growth Rate (CAGR) of over 20% over the medium-term.

Associate Health Minister David Seymour and Health Minister Simeon Brown are pleased that hundreds of thousands of New ...